We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+12.19%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$16.9B
AUM Growth
-$1.28B
Cap. Flow
-$3.58B
Cap. Flow %
-21.13%
Top 10 Hldgs %
34.65%
Holding
323
New
13
Increased
38
Reduced
39
Closed
80

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$358M
2
CRM icon
Salesforce
CRM
+$251M
3
BABA icon
Alibaba
BABA
+$173M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$159M
5
SPGI icon
S&P Global
SPGI
+$119M

Top Sells

Rank Stock Value
1
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$497M
2
TWTR
Twitter, Inc.
TWTR
+$340M
3
ZEN
ZENDESK INC
ZEN
+$296M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$294M
5
META icon
Meta Platforms (Facebook)
META
+$245M

Sector Composition

Rank Sector Weight
1 Healthcare 32.5%
2 Technology 18.76%
3 Financials 14.5%
4 Industrials 8.38%
5 Communication Services 4.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
151
Tango Therapeutics
TNGX
$4.03B
$1.96M 0.01%
270,000
-30,000
-10% -$211K
AMRS
152
DELISTED
Amyris Inc.
AMRS
$1.53M 0.01%
1,000,000
-5,126,642
-84% -$11.4M
AEON icon
153
AEON Biopharma
AEON
$9.58M
$1.51M 0.01%
2,083
– –
GATE
154
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.5M 0.01%
150,000
-2,820,000
-95% -$28.3M
NSTD
155
DELISTED
Northern Star Investment Corp. IV
NSTD
$1M 0.01%
100,000
– –
NSTC
156
DELISTED
Northern Star Investment Corp. III
NSTC
$1M 0.01%
100,000
– –
COGT icon
157
Cogent Biosciences
COGT
$6.37B
$984K 0.01%
85,139
-160,000
-65% -$1.98M
OKLO
158
Oklo
OKLO
$7.83B
$975K 0.01%
98,300
– –
BTTX
159
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$911K 0.01%
813,556
-186,444
-19% -$275K
CLVR
160
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$819K ﹤0.01%
88,952
+6,722
+8% +$96.1K
SMC
161
Summit Midstream
SMC
$470M
$718K ﹤0.01%
43,055
– –
TECX
162
Tectonic Therapeutic
TECX
$736M
$528K ﹤0.01%
61,667
– –
EDU icon
163
New Oriental
EDU
$8.88B
$453K ﹤0.01%
13,000
– –
KRTX
164
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$432K ﹤0.01%
2,200
-77,800
-97% -$16.7M
MTAL.WS
165
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$405K ﹤0.01%
825,000
– –
OPAL icon
166
OPAL Fuels
OPAL
$64.4M
$260K ﹤0.01%
+35,725
New +$288K
GRND.WS
167
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$259K ﹤0.01%
+540,000
New +$319K
LUNRW
168
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$249K ﹤0.01%
950,000
– –
GOL
169
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$229K ﹤0.01%
85,838
– –
SLDPW icon
170
Solid Power Inc Warrant
SLDPW
$6.93M
$170K ﹤0.01%
405,316
– –
SEDA.WS
171
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$104K ﹤0.01%
866,250
– –
KCGI.WS
172
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$98.8K ﹤0.01%
581,400
– –
AAC.WS
173
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$93.3K ﹤0.01%
200,000
– –
FRXB.WS
174
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$83.5K ﹤0.01%
250,000
– –
SCRMW
175
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$78.6K ﹤0.01%
333,330
– –
5 6
7
8 9

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q4 2022 Portfolio in Review

As of Q4 2022, Thomas Steyer held 323 positions worth $16.9B, down 7% from $18.2B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Thomas Steyer withdrew a net $3.58B in Q4 2022, closing 80 positions and reducing 39 holdings. Its most notable exit was Change Healthcare Inc. Common Stock, an estimated $497M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 28% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Intuit worth $351M.

  • Thomas Steyer's largest Q4 2022 buy was Intuit: 902,100 shares worth $351M.
  • Thomas Steyer added most to Salesforce in Q4 2022, an estimated $251M increase.
  • Thomas Steyer's biggest Q4 2022 reduction was Clarivate, cutting an estimated $238M.
  • Thomas Steyer fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $497M.
  • Thomas Steyer's ten largest holdings make up 35% of its $16.9B portfolio in Q4 2022.
  • Thomas Steyer opened 13 new positions and closed 80 in Q4 2022.
  • Thomas Steyer's portfolio value fell 7% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.